Cargando…
Steroid-dependent pericarditis following anti-PD1 immunotherapy in a metastatic melanoma patient: a case report
BACKGROUND: Immune-related adverse events are increasingly prevalent in the oncologist’s practice. Cardiac adverse events are rare but can be life-threatening. Case reports of immune checkpoint inhibitor (ICI)–related pericarditis are scarce and so is the scientific evidence for its management. This...
Autores principales: | Verhaert, Marthe, Mebis, Jeroen, Aspeslagh, Sandrine, von Kemp, Berlinde |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10019811/ https://www.ncbi.nlm.nih.gov/pubmed/36937234 http://dx.doi.org/10.1093/ehjcr/ytad112 |
Ejemplares similares
-
Modification of the Tumor Microenvironment Enhances Anti-PD-1 Immunotherapy in Metastatic Melanoma
por: Shi, Guilan, et al.
Publicado: (2022) -
Quantitative monitoring of circulating tumor DNA predicts response of cutaneous metastatic melanoma to anti-PD1 immunotherapy
por: Herbreteau, Guillaume, et al.
Publicado: (2018) -
Clinical, histological and molecular predictors of metastatic melanoma responses to anti-PD-1 immunotherapy
por: Dupuis, Frantz, et al.
Publicado: (2018) -
Circulating Tumor DNA Early Kinetics Predict Response of Metastatic Melanoma to Anti-PD1 Immunotherapy: Validation Study
por: Herbreteau, Guillaume, et al.
Publicado: (2021) -
Lymphocytic Perimyocarditis Masquerading as Steroid-Dependent Recurrent Pericarditis
por: Dugan, Eunice S., et al.
Publicado: (2023)